Nabil Asaad, PhD

Senior Associate

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

CV ansehen CV ausblenden

Aktuelle News & Insights

Life Sciences & Healthcare

Global pharma groups Eli Lilly and AbbVie withdraw from UK’s branded medicines voluntary scheme

18. Januar 2023
Briefing

von Nabil Asaad, PhD und Lauren Mounteney

Klicken Sie hier für Details
computing
Interface - Quantum computing - the next really big thing

Using quantum computing in life sciences

Nabil Asaad looks at the potential for quantum computing to revolutionise life sciences.

14. März 2022

von Nabil Asaad, PhD

2 von 4 Insights

Klicken Sie hier für Details
Life Sciences & Healthcare

Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis

29. Oktober 2021

von Colin McCall und Nabil Asaad, PhD

Klicken Sie hier für Details
Cambridge

Ross McNaughton recognised in The Lawyer's 2023 Hot 100

23. Januar 2023

von Ross McNaughton

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.